Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maya M. Makatini is active.

Publication


Featured researches published by Maya M. Makatini.


Bioorganic & Medicinal Chemistry Letters | 2011

Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease

Maya M. Makatini; Katja Petzold; Shimoga N. Sriharsha; Mahmoud E. S. Soliman; Bahareh Honarparvar; Per I. Arvidsson; Yasien Sayed; Patrick Govender; Glenn E. M. Maguire; Hendrik G. Kruger; Thavendran Govender

In this study, we present the first account of pentacycloundecane (PCU) peptide based HIV-protease inhibitors. The inhibitor exhibiting the highest activity made use of a natural HIV-protease substrate peptide sequence, that is, attached to the cage (PCU-EAIS). This compound showed nanomolar IC(50) activity against the resistance-prone wild type C-South African HIV-protease (C-SA) catalytic site via a norstatine type functional group of the PCU hydroxy lactam. NMR was employed to determine a logical correlation between the inhibitory concentration (IC(50)) results and the 3D structure of the corresponding inhibitors in solution. NMR investigations indicated that the activity is related to the chirality of the PCU moiety and its ability to induce conformations of the coupled peptide side chain. The results from docking experiments coincided with the experimental observed activities. These findings open up useful applications for this family of cage peptide inhibitors, considering the vast number of alternative disease related proteases that exist.


ChemMedChem | 2012

Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors : Biological Screening, 2D NMR, and Molecular Simulation Studies

Bahareh Honarparvar; Maya M. Makatini; Sachin A. Pawar; Katja Petzold; Mahmoud E. S. Soliman; Per I. Arvidsson; Yasien Sayed; Thavendran Govender; Glenn E. M. Maguire; Hendrik G. Kruger

Novel compounds incorporating a pentacycloundecane (PCU) diol moiety were designed, synthesized, and evaluated as inhibitors of the wild‐type C‐South African (C‐SA) HIV‐1 protease. Seven compounds are reported herein, three of which displayed IC50 values in the 0.5–0.6 μM range. The cytotoxicity of PCU cage peptides toward human MT‐4 cells appears to be several orders of magnitude less toxic than the current antiviral medications ritonavir and lopinavir. NMR studies based on the observed through‐space 1H,1H distances/contacts in the EASY‐ROESY spectra of three of the considered PCU peptide inhibitors enabled us to describe their secondary solution structure. Conserved hydrogen bonding interactions were observed between the hydroxy group of the PCU diol inhibitors and the catalytic triad (Asp25, Ile26, Gly27) of HIV protease in docking and molecular dynamics simulations. The biological significance and possible mode of inhibition by PCU‐based HIV protease inhibitors discussed herein facilitates a deeper understanding of this family of inhibitors and their potential application to a vast number of alternative diseases related to proteases.


Journal of Enzyme Inhibition and Medicinal Chemistry | 2013

Synthesis, 2D-NMR and molecular modelling studies of pentacycloundecane lactam-peptides and peptoids as potential HIV-1 wild type C-SA protease inhibitors

Maya M. Makatini; Katja Petzold; Cláudio Nahum Alves; Per I. Arvidsson; Bahareh Honarparvar; Patrick Govender; Thavendran Govender; Hendrik G. Kruger; Yasien Sayed; JerônimoLameira; Glenn E. M. Maguire; Mahmoud E. S. Soliman

In this study, eight non-natural peptides and peptoids incorporating the pentacycloundecane (PCU) lactam were designed and synthesized as potential inhibitors of the wild type C-SA HIV-protease. Five of these inhibitors gave IC50 values ranging from 0.5 up to 0.75 µM against the resistance-prone wild type C-South African HIV-protease. NMR EASY-ROESY studies enabled us to describe the secondary structure of three of these compounds in solution. The 3D structures of the selected cage peptides were also modelled in solution using QM/MM/MD simulations. Satisfactory agreement between the NMR observations and the low energy calculated structures exists. Only one of these inhibitors (11 peptoid), which showed the best IC50(0.5 µM), exhibited a definable 3-D structure in solution. Autodock4 and AutodockVina were used to model the potential interaction between these inhibitors and the HIV-PR. It appears that the docking results are too crude to be correlated with the relative narrow range of experimental IC50 values (0.5–10 µM). The PCU-peptides and peptoides were several orders less toxic (145 μM for 11 and 102 μM for 11 peptoid) to human MT-4 cells than lopinavir (0.025 μM). This is the first example of a polycyclic cage framework to be employed as an HIV-PR transition state analogue inhibitor and can potentially be utilized for other diseases related proteases.Graphical abstract: PCU-diastereomers peptide and peptoid inhibitors with arrows showing the observed EASY-ROESY correlations.


Magnetic Resonance in Chemistry | 2010

Synthesis and NMR assignment of pentacycloundecane precursors of potential pharmaceutical agents.

Oluseye K. Onajole; Maya M. Makatini; Patrick Govender; Thavendran Govender; Glenn E. M. Maguire; Hendrik G. Kruger

The synthesis and complete NMR elucidation of eight novel pentacycloundecane (PCU) derivatives are reported. These compounds are precursors in the synthesis of PCU‐based anti‐tuberculosis (TB) agents and potential human immunodeficiency virus (HIV) protease inhibitors. Two‐dimensional (2D) NMR techniques were used to assign the NMR spectra for these compounds. Substitution of the cage molecule at (C‐8/11) further complicates the assignment, since some of the substituted alkyl chain groups overlap with the cage proton signals. The side chain heteroatoms also introduce a rare through‐space deshielding effect to some of the carbon atoms of the cage skeleton. Ring strain in the rigid cage skeleton appears to induce drastic electronic changes in some parts of the cage framework. This observation is more dramatic for the C‐4 methylene group of the cage diols and the cage ethers. Copyright


Magnetic Resonance in Chemistry | 2008

Synthesis and NMR elucidation of novel penta-cycloundecane amine derivatives as potential antituberculosis agents

Oluseye K. Onajole; Thavendran Govender; Maya M. Makatini; Hendrik G. Kruger

The synthesis and NMR elucidation of five novel penta‐cycloundecane amine derivatives are reported. These compounds are potential antituberculosis agents. The 1H and 13C spectra showed major overlapping of methine signals of the cage skeleton making it extremely difficult to elucidate these compounds. The overlapping occurs as a result of the additions made to the carbonyl carbon (C‐8/C‐11) of the cage. The two‐dimensional NMR technique proved to be a useful tool in overcoming this problem. All compounds reported are meso compounds thereby not only simplifying the NMR structure elucidation, but also making it indeed possible. Copyright


Journal of Peptide Science | 2012

Synthesis and NMR elucidation of novel tetrapeptides

Maya M. Makatini; Thashini Chetty; Oluseye K. Onajole; Thavendran Govender; Patrick Govender; Glenn E. M. Maguire; Hendrik G. Kruger

The synthesis and NMR elucidation of Ala‐Val‐Pro‐Ile and five novel peptide‐based derivatives are reported. These peptides mimic the natural second mitochondria‐derived activator of caspase (Smac) protein. Purification was achieved using preparative HPLC and the NMR elucidation of all compounds is reported for the first time. A series of overlapping signals were observed in the 1D NMR spectra thus making assignment a difficult task to undertake. The use of 2D NMR techniques with the inclusion of efficient adiabatic symmetrized ROESY proved to be an effective tool in overcoming these difficulties. Copyright


Magnetic Resonance in Chemistry | 2010

Synthesis and NMR elucidation of novel pentacycloundecane-based peptides

Mohamed S. Altaib; Per I. Arvidsson; Thavendran Govender; Glenn E. M. Maguire; Maya M. Makatini; Oluseye K. Onajole; Hendrik G. Kruger

The synthesis and NMR elucidation of two novel pentacycloundecane (PCU)‐based peptides are reported. The PCU cage amino acids were synthesised as racemates and the incorporation of the cage amino acid with (S)‐natural amino acids produced diastereomeric peptides. The diastereomeric ‘cage’ peptides were separated using preparative HPLC and the NMR elucidation of these PCU containing peptides are reported for the first time. The 1H and 13C NMR spectra showed series of overlapping signals of the cage skeleton and that of the peptide, making it extremely difficult to resolve the structure using one‐dimensional NMR techniques only. The use of two‐dimensional NMR techniques proved to be a highly effective tool in overcoming this problem. Copyright


European Journal of Medicinal Chemistry | 2011

Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: A hybrid 2D NMR and docking/QM/MM/MD approach

Maya M. Makatini; Katja Petzold; Shimoga N. Sriharsha; Nombuso Ndlovu; Mahmoud E. S. Soliman; Bahareh Honarparvar; Raveen Parboosing; Anneta Naidoo; Per I. Arvidsson; Yasien Sayed; Patrick Govender; Glenn E. M. Maguire; Hendrik G. Kruger; Thavendran Govender


European Journal of Medicinal Chemistry | 2012

Synthesis, screening and computational investigation of pentacycloundecane-peptoids as potent CSA-HIV PR inhibitors

Maya M. Makatini; Katja Petzold; Per I. Arvidsson; Bahareh Honarparvar; Thavendran Govender; Glenn E. M. Maguire; Raveen Parboosing; Yasien Sayed; Mahmoud E. S. Soliman; Hendrik G. Kruger


Structural Chemistry | 2008

Synthesis and NMR elucidation of pentacyclo-undecane diamine derivatives as potential anti-tuberculosis drugs

Thavendran Govender; Hendrik G. Kruger; Maya M. Makatini; Oluseye K. Onajole

Collaboration


Dive into the Maya M. Makatini's collaboration.

Top Co-Authors

Avatar

Hendrik G. Kruger

University of KwaZulu-Natal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Katja Petzold

University of KwaZulu-Natal

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasien Sayed

University of the Witwatersrand

View shared research outputs
Top Co-Authors

Avatar

Oluseye K. Onajole

University of KwaZulu-Natal

View shared research outputs
Top Co-Authors

Avatar

Patrick Govender

University of KwaZulu-Natal

View shared research outputs
Top Co-Authors

Avatar

Raveen Parboosing

National Health Laboratory Service

View shared research outputs
Researchain Logo
Decentralizing Knowledge